Tags:BioTechDevelopmentDrugMedtechOptimizeResearchTechnology
Ambit Biosciences is combining the power of our KINOMEscan™ kinase profiling technology with an innovative licensing strategy and a history of kinase expertise to discover, optimize and advance a sustainable pipeline of small molecule kinase inhibitors for the treatment of cancer.
Location: United States, California, San Diego
Member count: 51-200
Total raised: $80M
Founded date: 2000

Investors 1

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
06.11.2012-$50M-finsmes.co...
10.06.2011Series D$30M-finsmes.co...

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
06.11.2012Ambit Bios...Venture investors have loosene...Venture Ca...-fiercebiot...
06.11.2012 Ambit ...San Diego-based Ambit Bioscien...--socaltech....
06.11.2012Ambit Bios... SAN DIEGO, CA, Privately hel...--vcnewsdail...
06.11.2012Ambit Bios...Ambit Biosciences Inc., a San ...funding S...-finsmes.co...
10.06.2011 Ambit ...San Diego-based Ambit Bioscien...--socaltech....
10.06.2011Ambit Bios...Ambit Biosciences, a San Diego...funding U...-finsmes.co...
24.07.2009Startups J...Share Share on Facebook Share ...-Bruce V. B...xconomy.co...
29.06.2009 Ambit ...San Diego-based Ambit Bioscien...--socaltech....
18.01.2008VC funding...Venture-capital funding contin...--venturebea...
14.11.2007Life scien...Featured companies: Advanced B...--venturebea...
Show more